Starpharma Holdings Limited (OTCMKTS:SPHRY) Short Interest Update

Starpharma Holdings Limited (OTCMKTS:SPHRYGet Free Report) saw a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 2,700 shares, a drop of 70.0% from the March 15th total of 9,000 shares. Based on an average daily trading volume, of 1,400 shares, the short-interest ratio is presently 1.9 days.

Starpharma Price Performance

Shares of SPHRY stock remained flat at $0.86 during trading hours on Thursday. Starpharma has a 1 year low of $0.77 and a 1 year high of $3.45. The firm has a 50-day moving average price of $0.90 and a 200 day moving average price of $0.96.

Starpharma Company Profile

(Get Free Report)

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.

See Also

Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.